• 5-hme-dCTP in Epigenetic DNA Modification: Protocols & Insig

  2026-04-29

  5-hme-dCTP (5-Hydroxymethyl-2’-deoxycytidine-5’-Triphosphate) empowers precise mapping and manipulation of 5-hydroxymethylcytosine for plant epigenetic research. Discover workflow enhancements, troubleshooting strategies, and the impact of this modified nucleotide on advancing drought resilience studies.

• Gefitinib (ZD1839): Reliable EGFR Inhibition for Cancer Rese

  2026-04-28

  This article provides evidence-based guidance on deploying Gefitinib (ZD1839), SKU A8219, for cell viability and cytotoxicity assays in cancer research. Drawing on recent literature, validated workflows, and real-world lab scenarios, it demonstrates how Gefitinib enables reproducible EGFR pathway inhibition and supports advanced tumor model studies. Researchers will gain actionable insights into protocol optimization, data interpretation, and vendor reliability.

• MDL 28170, Calpain and Cathepsin B Inhibitor: Reliable Assay

  2026-04-28

  This article addresses laboratory challenges in cell viability, apoptosis, and neuroprotection research by evaluating the application of 'MDL 28170, Calpain and Cathepsin B Inhibitor, Selective' (SKU A4412). Drawing on recent peer-reviewed studies and workflow best practices, it demonstrates how SKU A4412 delivers reproducibility, sensitivity, and translational value for advanced cytotoxicity and disease modeling assays.

• Tamsulosin: Precision α1A Receptor Antagonist for Urological

  2026-04-27

  Tamsulosin, or (R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide, enables high-fidelity modeling of smooth muscle relaxation and urinary tract modulation, especially for ureteral stone expulsion and postoperative retention. Leveraging APExBIO's rigorously characterized Tamsulosin facilitates robust, reproducible GPCR pathway studies and translational urological assays.

• S-Adenosylhomocysteine: Optimizing SAM/SAH Ratio in Neural R

  2026-04-27

  S-Adenosylhomocysteine (SAH) accelerates translational research by enabling precise methyltransferase inhibition and SAM/SAH ratio modulation, essential for metabolic and neural differentiation studies. This article delivers actionable workflows, troubleshooting strategies, and data-driven guidance for leveraging APExBIO's SAH in advanced experimental contexts.

• Daphnepedunin A Targets Cdc42 to Mitigate Kidney Fibrosis

  2026-04-26

  This study identifies daphnepedunin A (DA), a small molecule from Wikstroemia chamaedaphne, as a potent inhibitor of kidney fibrosis by directly targeting Cdc42-mediated GSK-3β/β-catenin signaling. The work advances understanding of fibrotic mechanisms and suggests new avenues for chronic kidney disease therapy.

• Cy5-UTP: Transforming RNA Labeling for Advanced Transcriptom

  2026-04-25

  Cy5-UTP (Cyanine 5-UTP) unlocks high-sensitivity, direct fluorescent RNA labeling for workflows such as FISH, dual-color expression arrays, and mechanistic RNA–protein interaction studies. Its robust performance and seamless integration with T7 polymerase protocols position it as a keystone reagent for both foundational research and translational applications.

• Disrupting c-Myc/Max: Strategic Guidance for Translational R

  2026-04-24

  This thought-leadership article provides a comprehensive exploration of the mechanistic and translational power of 10058-F4, a c-Myc-Max dimerization inhibitor, for oncology and stem cell researchers. Building on recent breakthroughs in telomerase regulation and DNA repair, it delivers actionable insights for experimental design and future therapeutic innovation, while distinguishing itself from standard product literature.

• GI 254023X: Applied ADAM10 Inhibition in Vascular and Oncolo

  2026-04-24

  GI 254023X stands out as a highly selective ADAM10 inhibitor, enabling precise dissection of cell signaling, apoptosis, and vascular barrier studies where broad-spectrum inhibitors often fail. This article details actionable workflows, advanced experimental use-cases, and troubleshooting strategies to maximize reproducibility and impact in both oncology and vascular research.

• EGTA in Calcium Signaling: Optimizing Neuroprotection Assays

  2026-04-23

  EGTA (egtaszic acid) enables precise control of calcium-dependent processes in advanced neuroprotection and apoptosis assays. Explore optimized workflows, troubleshooting strategies, and real-world experimental parameters for leveraging this selective calcium chelator in translational research.

• NSAID Cytotoxicity in Canine Osteosarcoma: In Vitro Insights

  2026-04-23

  This study evaluates the cytotoxic effects of deracoxib and piroxicam on canine osteosarcoma cell lines, revealing that deracoxib demonstrates greater potency than piroxicam, without inducing apoptosis at tested concentrations. Findings inform the search for adjunct therapies in veterinary oncology and highlight the need for agents with selective antiproliferative effects and minimal off-target toxicity.

• Sodium Orthovanadate: Enhancing Phosphorylation State Preser

  2026-04-22

  Sodium Orthovanadate (Na3VO4) is a gold-standard tool for preserving protein phosphorylation states in kinase and metabolic assays. This article details advanced workflows, troubleshooting strategies, and the unique translational value of APExBIO’s high-purity Na3VO4 for robust, reproducible signal transduction studies.

• Resazurin Sodium Salt: Precision Fluorogenic Indicator for C

  2026-04-22

  Resazurin sodium salt has redefined cell viability and cytotoxicity assays with its sensitive fluorogenic readout, enabling high-throughput applications from iPSC-based disease modeling to cancer drug screening. Discover optimized workflows, troubleshooting insights, and reference-driven innovations that set this indicator apart for translational research.

• Amyloid β-Peptide (1-42): Workflows & Troubleshooting in AD

  2026-04-21

  Unlock reproducible Alzheimer's disease models with Amyloid β-Peptide (1-42) (Aβ42) using evidence-based workflows and troubleshooting strategies. This guide translates bench research into practical assay choices, optimizing neurotoxicity and microglial activation studies with APExBIO's trusted Aβ42 peptide.

• EdU Flow Cytometry Assay Kits (Cy5): Technical Workflow Guid

  2026-04-21

  The EdU Flow Cytometry Assay Kits (Cy5) enable sensitive detection of cell proliferation by quantifying S-phase DNA synthesis with minimal sample disruption. Ideal for research requiring precise flow cytometry cell proliferation readouts, these kits are not suited for fixed tissue imaging or non-DNA synthesis applications. Researchers should follow recommended workflow parameters for optimal results.

407 records 17/28 page Previous Next First page 上5页 1617181920 下5页 Last page